{"id":"W2416001425","doi":"10.1080/13543784.2016.1195808","title":"Investigational targeted therapies for the treatment of testicular germ cell tumors","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; Clinical trial; Oncology; Internal medicine; Targeted therapy; Germ cell tumors; Sunitinib; Disease; Ifosfamide; Chemotherapy; Cancer; Lymphoma; Etoposide; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001281281,0.0006639577,0.001239538,0.0002106997,0.0002335846,0.00002939959,0.0002052468,0.0002184062,0.0002134365],"category_scores_gemma":[0.0003596957,0.0003352322,0.001050787,0.000248965,0.0005178817,0.00006015823,0.00002250084,0.0001070428,0.0001063624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003775958,"about_ca_system_score_gemma":0.001741124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002574177,"about_ca_topic_score_gemma":1.552786e-7,"domain_scores_codex":[0.9973716,0.0001482016,0.0008508406,0.0005922465,0.0007230199,0.0003140794],"domain_scores_gemma":[0.9957351,0.002310206,0.000731145,0.0006035912,0.0002693927,0.0003505542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001221898,0.002221488,0.0001790601,0.00363071,0.002289015,0.00001225137,0.0008657047,0.00001291691,0.00003137409,0.01511534,0.01224104,0.9632789],"study_design_scores_gemma":[0.001915924,0.0009584618,0.0003314659,0.009005336,0.000325361,0.00002028998,0.00002822877,0.00005598153,0.000170214,0.001365738,0.9854916,0.0003313849],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004817014,0.9937949,0.00006632208,0.001406444,0.0004945256,0.002940078,0.001036408,0.00006722267,0.0001459573],"genre_scores_gemma":[0.0001591646,0.9898189,0.002456855,0.0004844059,0.0009660041,0.00266352,0.002766397,0.0001067172,0.000578074],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9732506,"threshold_uncertainty_score":0.99991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06552153533269944,"score_gpt":0.360707653935143,"score_spread":0.2951861186024436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}